Bhubaneswar (Odisha) [India], July 21 (ANI): Ahead of the commencement of the human clinical trial of COVID-19 vaccine, Preventive and Therapeutic Clinical Trial Unit was inaugurated at the Institute of Medical Sciences and SUM Hospital on Monday.
New Delhi [India], July 20 (ANI): Two days after announcing that All India Institute of Medical Sciences (AIIMS) Delhi will conduct the human clinical trial of the indigenously developed COVID-19 vaccine Covaxin, the head of Centre for Community Medicine Department in AIIMS, Dr Sanjay K Rai
New Delhi [India], July 20 (ANI): Certain areas of the national capital have hit their peak in COVID-19 cases while certain other areas in the city are yet to reach the peak, said AIIMS Director Dr Randeep Guleria on Monday. He further said that there is not much evidence of community tra
New Delhi [India], July 18 (ANI): The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin.
Rohtak (Haryana) [India], July 17 (ANI): Human trials of Covaxin, India's first vaccine candidate against coronavirus, began at Post-Graduate Institute (PGI) of Medical Sciences in Rohtak on Friday.
Mumbai (Maharashtra) [India], July 4 (ANI): Former Maharashtra Chief Minister and Congress leader Prithviraj Chavan on Saturday said that Indian Council of Medical Research (ICMR) is rushing for an "unrealistic" timeline of 15 August for indigenous COVID-19 vaccine.
New Delhi [India], July 3 (ANI) The Indian Council of Medical Research (ICMR) DG Balram Bhargava has written a letter to Bharat Biotech and principal investigators of medical colleges to complete the trial procedure of indigenous COVID-19 vaccine in a fast track method, so that results of
New Delhi [India], June 30 (ANI): The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human clinical trials to develop an indigenous vaccine for COVID-19 -- in the name COVAXIN.
Hyderabad (Telangana) [India], June 30 (ANI): Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).